Carlyle Secured Lending (CGBD) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
3 Feb, 2026Executive summary
Net investment income for Q3 2024 was $24.0 million, or $0.47 per share; adjusted NII was $0.49 per share, reflecting one-time CLO reset costs.
Net asset value per share as of September 30, 2024, was $16.85, down slightly from the prior quarter.
Portfolio comprised 175 investments in 128 companies across 25+ industries, with a fair value of $1.71 billion and 94% in senior secured loans.
Board declared a Q4 2024 dividend of $0.40 per share plus a $0.05 supplemental dividend, payable January 17, 2025.
Merger with Carlyle Secured Lending III is on track to close by end of Q1 2025, with preferred stock to be exchanged for common stock at NAV.
Financial highlights
Total investment income for Q3 2024 was $56 million, slightly lower than prior quarter due to lower average portfolio balance and yields.
Net investment income was $24 million ($0.47/share); adjusted NII was $25 million ($0.49/share).
Aggregate realized and unrealized net loss was about $5 million for the quarter.
Dividend coverage at 118% for the quarter; annualized dividend yield was 10.7% on Q3 NAV.
Basic EPS for Q3 2024 was $0.37; for the nine months ended September 30, 2024, basic EPS was $1.28.
Outlook and guidance
Confident in ability to meet/exceed $0.40 base dividend, but expect some earnings contraction due to lower base rates and tighter spreads.
Merger with CSL III expected to close in Q1 2025, subject to approvals.
M&A pipeline expanding; originations expected to remain strong into 2025.
Target leverage at merger close is 1.1x; currently at 0.95x, expected to be above 1.0x by quarter-end.
Focus remains on direct origination of secured debt to U.S. middle market companies.
Latest events from Carlyle Secured Lending
- Record originations, stable NAV, and new JVs set the stage for higher returns in 2026.CGBD
Q4 202525 Feb 2026 - Q2 net investment income was $0.51/share, NAV $16.95, and a merger with CSL III was announced.CGBD
Q2 20242 Feb 2026 - Q4 net investment income held steady as portfolio, liquidity, and dividend coverage strengthened.CGBD
Q4 202423 Dec 2025 - Vote sought to authorize share issuance below NAV for up to 25% of shares over 12 months.CGBD
Proxy Filing1 Dec 2025 - Stockholders will vote on two director nominees and auditor ratification, with Board support.CGBD
Proxy Filing1 Dec 2025 - Shareholders will vote on authorizing up to 25% of shares to be issued below NAV for 12 months.CGBD
Proxy Filing1 Dec 2025 - Annual proxy outlines voting items and governance, with no filing fee required.CGBD
Proxy Filing1 Dec 2025 - Definitive proxy statement filed for annual meeting with key proposals for shareholder vote.CGBD
Proxy Filing1 Dec 2025 - CSL III merger and portfolio growth offset earnings pressure from lower yields and rising non-accruals.CGBD
Q1 202525 Nov 2025